Cardioprotective effect Linagliptin (DPP-4 Inhibitor) against myocardial infarction induced in rats with metabolic syndrome

Effect of Sodium Glucose Co-transporter Type 2 Inhibitors on The Infract size among Diabetic Patients With ST Segment Elevation Myocardial Infarction Undergoing Primary Percutane

The Effect of SGLT2 Inhibitors on the Development of Contrast-Induced Nephropathy in Diabetic Patients with Non-ST Segment Elevation Myocardial Infarction

The Potential Ameliorative Effect of Empagliflozin on Myocardium in Cardiorenal Syndrome 3 via Targeting Mitophagy and Mitochondrial Biogenesis in Adult Male Albino Rat Model: Bi

Protective effect of dapagliflozin against non-alcoholic fatty liver in rats AMPK/SIRT1 pathway activation

Reno Protective Effect of Sodium Glucose Cotransporter-2 Inhibitor (Dapagliflozin) in Type 2 Diabetic Patients

THE PROTECTIVE ROLE OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR, LINAGLIPTIN IN ACUTE AND CHRONIC KIDNEY INJURY CONDITIONS

Possible Protective Mechanisms of Sitagliptin against Isoproternol Induced Myocardial Injury in Rat

Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction Induced Experimentally in Diabetic Rats

The Potential Protective Effect of Vildagliptin on Paw Edema: An Experimental Study